Company Presentation • 17 Aug 2026 20:00
H1 2026
Company Presentation • 23 Mar 2026 20:00
H2 2025
Company Presentation • 28 Aug 2023 14:00
H1 2023
Company Presentation • 18 Aug 2025 20:00
H1 2025
Company Presentation • 24 Mar 2025 16:00
𝛼SK or SearchENTITY
Sichuan Kelun-Biotech Biopharmaceutical (6990 HK)
Sichuan Kelun-Biotech Biopharmaceutical (6990 HK)
113
Analysis
Health Care • China
Sichuan Kelun-Biotech Biopharmaceutical is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative biological and small molecule drugs, particularly Antibody-Drug Conjugates (ADCs). It addresses unmet medical needs in oncology, autoimmune disorders, and metabolic diseases, with key products including sacituzumab tirumotecan and trastuzumab botidotin. The company is headquartered in Chengdu, Sichuan, China, and was founded in 2016.
morex